OPTIMIZATION OF PATIENTS MANAGEMENT IN MYOCARDIAL INFARCTION COMORBIDITY WITH NON-ALCOHOLIC FATTY LIVER DISEASE

OPTIMIZATION OF PATIENTS MANAGEMENT IN MYOCARDIAL INFARCTION COMORBIDITY WITH NON-ALCOHOLIC FATTY LIVER DISEASE

Aim. To investigate on the efficacy of thiotriazoline (TTZ) in complex management of acute myocardial infarction (AMI) patients with hepatic steatosis.Material and methods. Totally, 32 left ventricle AMI patients included, comorbid with non-alcoholic fatty liver disease. Assessment of electrical act...

Full description

Saved in:

Bibliographic Details
Main Author:	I. E. Belaya
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2017-12-01
Series:	Российский кардиологический журнал
Subjects:	acute period of myocardial infarction non-alcoholic fatty liver disease vectorcardiography thiotraizoline
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1061
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MODERN ELECTROCARDIOGRAPHIC METHODS OF ESTIMATION OF CORONARY REPERFUSION AT THROMBOLYSIS IN ACUTE PERIOD OF MYOCARDIAL INFARCTION
by: I. Ye. Belaya
Published: (2014-04-01)

VECTOR ELECTROCARDIOGRAPHY IN THE DIAGNOSTICS OF FOCAL CHANGES IN THE MYOCARDIUM
by: I. Ye. Belaya, et al.
Published: (2015-04-01)

Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)

Curcumin and non-alcoholic fatty liver disease
by: Nasrin Sharifi, et al.
Published: (2024-06-01)

Improvement of non-alcoholic fatty liver disease treatment
by: P. I. Seliverstov, et al.
Published: (2014-10-01)

Evolving ideas on non-alcoholic fatty liver disease: from risk to catastrophe
by: Yu. M. Stepanov, et al.
Published: (2020-04-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE
by: O. M. Drapkina, et al.
Published: (2017-11-01)

Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01)

The effect of non-alcoholic fatty liver disease on the development of cardiovascular diseases
by: N. A. Starodubtseva, et al.
Published: (2025-03-01)

Genetic aspects of non-alcoholic fatty liver disease development
by: V. A. Akhmedov, et al.
Published: (2021-06-01)

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
by: Ye. N. Shirokova
Published: (2023-08-01)

Pathogenic role of lipids in non-alcoholic fatty liver disease
by: Yu. O. Shulpekova
Published: (2012-02-01)

Liver and Nutrition. An Optimal Diet for Non-Alcoholic Fatty Liver Disease
by: M. V. Mayevskaya, et al.
Published: (2018-11-01)

Metabolic effects of ursodeoxycholic acid in patients with non-alcoholic fatty liver disease
by: V. A. Akhmedov
Published: (2024-04-01)

Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
by: S. E. Evstifeeva, et al.
Published: (2022-10-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

Food fibers in metabolic syndrome and non-alcoholic fatty liver disease
by: E. V. Onuchina
Published: (2021-06-01)

Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy
by: A. V. Nelidova, et al.
Published: (2022-01-01)

Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk
by: O. M. Drapkina, et al.
Published: (2016-09-01)

Post myocardial infarction care by the GP
by: J.M. Bennett
Published: (2004-12-01)

INTRAOPERATIVE RISK FACTORS OF MYOCARDIAL INFARCTION IN NON-CARDIAC SURGERIES
by: Z. Т. Kotvitskаya, et al.
Published: (2018-05-01)

The Interplay of Iron and Lipid Homeostasis in Non-Alcoholic Fatty Liver Disease
by: Clinton J. Kidman, et al.
Published: (2025-03-01)

Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Guntur Darmawan, et al.
Published: (2017-08-01)

Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
by: Guntur Darmawan, et al.
Published: (2017-08-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

CHANGES IN THE DENTAL STATUS OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
by: D.V. Emelyanov, et al.
Published: (2022-03-01)

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity
by: I. V. Logacheva, et al.
Published: (2019-01-01)

Non-alcoholic fatty liver disease: a heterogeneous phenotype. Pleiotropic effects of ursodeoxycholic acid
by: E. A. Ljaljukova
Published: (2023-08-01)

The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease
by: T. S. Krolevets, et al.
Published: (2020-12-01)

Pathogenetic Targets of Sea Algae Polysaccharides in Non-Alcoholic Fatty Liver Disease
by: S. P. Kryzhanovsky, et al.
Published: (2024-11-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG OBESE PREGNANT WOMEN
by: I. O. Makarov, et al.
Published: (2016-09-01)

Modern views on the management tactics of patients with sarcopenia in combination with non-alcoholic fatty liver disease
by: V. A. Akhmedov, et al.
Published: (2024-08-01)

Identification of palmitoylated biomarkers in non-alcoholic fatty liver disease via integrated bioinformatics analysis and machine learning
by: Zheng Liu, et al.
Published: (2025-08-01)

Non-invasive liver fibrosis markers are increased in obese individuals with non-alcoholic fatty liver disease and the metabolic syndrome
by: Anders Askeland, et al.
Published: (2025-03-01)

The association between serum pinenes and non-alcoholic fatty liver disease based on the NHANES 2013–2014
by: Tuo Xiao, et al.
Published: (2025-09-01)

Deciphering the role of dietary modifications and gut dysbiosis in Non-Alcoholic Fatty Liver Disease
by: Meenakshi Vachher, et al.
Published: (2025-06-01)

PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
by: V. P. Mikhin, et al.
Published: (2017-12-01)